In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-11 of 11 for your search:
Drug:  liposome-encapsulated doxorubicin citrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: Biocompatible-Korea, NCT01332669

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 an over
Sponsor: Pharmaceutical / Industry
Protocol IDs: STM01-102, NCT00294996

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22224, 2009-011400-33, NCT00976911

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: C19562/2037, 2008-000709-12, NCT00712881

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: GOG/2007-01, 2007-005173-56, NCT00721747

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: MUI-AGO-15, MUI-AGO-15, EUDRACT-2007-004060-40, EU-21027, NCT01100359

7.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: MUI-AGO-10, MUI-AGO-10, EUDRACT-2008-008746-20, EU-21028, NCT01100372

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDX011-03, NCT01156753

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ABCSG 32, 2010-023324-25, NCT01367028

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: IIL - HD0803, EudraCT Number 2009-013839-37, NCT01523847

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 74
Sponsor: Other
Protocol IDs: SOLTI-1002, 2012-001201-24, NCT01669239
New Search